Latest Indian Chemical and Petrochemical News, statistics, Research and events... indianchemicalnews.com

Results For "Biotechnology-Industry-Research-Assistance-Council"

9 News Found

ORSL, IIT Bombay, and IIT Kharagpur secure DBT-BIRAC grant to launch India’s first pilot-scale Bio-CCU platform
Sustainability | December 10, 2025

ORSL, IIT Bombay, and IIT Kharagpur secure DBT-BIRAC grant to launch India’s first pilot-scale Bio-CCU platform

The initiative aims to build India’s first pilot-scale BIO-CCU platform specifically engineered for next-generation CO₂ valorization


MNRE Minister Joshi announces Rs. 100 crore Call for Proposals for biomass-based hydrogen pilots
Hydrogen | November 12, 2025

MNRE Minister Joshi announces Rs. 100 crore Call for Proposals for biomass-based hydrogen pilots

The scheme will be implemented through BIRAC (Biotechnology Industry Research Assistance Council) to encourage participation from industries, start-ups, and research institutions


Global Bio India unveils 30 breakthrough startups: Dr. Jitendra Singh
Policy | September 14, 2024

Global Bio India unveils 30 breakthrough startups: Dr. Jitendra Singh

India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030


Bioenergy scenario in India @2047: Shishir Joshipura, MD & CEO, Praj Industries
Opinion | June 30, 2023

Bioenergy scenario in India @2047: Shishir Joshipura, MD & CEO, Praj Industries

Bioenergy triggers carbon neutral cycles, as carbon absorbed by the plants from the atmosphere during photosynthesis is released during combustion of biofuels


Haffkine Biopharma to produce 22.8 Cr doses of Covaxin
Chemical | June 03, 2021

Haffkine Biopharma to produce 22.8 Cr doses of Covaxin

For undertaking production, the company has been provided a Rs. 65 crore grant by the centre and Rs. 94 crore from the government of Maharashtra


India aims to administer 100 crore vaccine doses by end-2021
General | May 18, 2021

India aims to administer 100 crore vaccine doses by end-2021

Both Serum Institute of India (SII) and Bharat Biotech are planning to cumulatively manufacture around 90-110 crore doses from June-December 2021 timeframe


Govt. to augment Covaxin production by 10 crore doses
Chemical | May 16, 2021

Govt. to augment Covaxin production by 10 crore doses

Financial support is being provided as a grant from the Government of India


Dr. Reddy’s seeks approval to continue Phase 3 trial
Chemical | January 13, 2021

Dr. Reddy’s seeks approval to continue Phase 3 trial

The Phase 2 study of Sputnik V was conducted on 100 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.


Dr. Reddy's and RDIF commence Phase 2/3 trials for Sputnik V
General | December 03, 2020

Dr. Reddy's and RDIF commence Phase 2/3 trials for Sputnik V

This will be a multicenter and randomized controlled study, which will include safety and immunogenicity study